Escherichia coli Nissle 1917-driven microrobots for effective tumor targeted drug delivery and tumor regression
- 31 July 2023
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 169, 477-488
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Zhejiang Province (LY20H300005, LY20H300006)
- National Natural Science Foundation of China (22078297, 51803181)
This publication has 37 references indexed in Scilit:
- In vitro and in vivo evaluation of stimuli-responsive vesicle from PEGylated hyperbranched PAMAM-doxorubicin conjugate for gastric cancer therapyInternational Journal of Pharmaceutics, 2016
- Running and tumbling with E. coli in polymeric solutionsScientific Reports, 2015
- Biomanufacturing and self-propulsion dynamics of nanoscale bacteria-enabled autonomous delivery systemsApplied Physics Letters, 2014
- Variation in swimming speed of Escherichia coli in response to attractantArchives of Microbiology, 2014
- Drug Resistance in Cancer: An OverviewCancers, 2014
- A pH-sensitive charge-conversion system for doxorubicin deliveryActa Biomaterialia, 2013
- Higher Motility Enhances Bacterial Density and Inflammatory Response in Dyspeptic Patients Infected with Helicobacter pyloriHelicobacter, 2012
- Anti-inflammatory modulation of immune response by probiotic Escherichia coli Nissle 1917 in human blood mononuclear cellsInnate Immunity, 2011
- Enabling Cargo‐Carrying Bacteria via Surface Attachment and Triggered ReleaseSmall, 2011
- Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live miceInternational Journal of Medical Microbiology, 2007